Bhavesh Mohan Lal, MD, UAMS College of Medicine, Little Rock, Arkansas, reviews a study designed to investigate the effects of prior exposure to BCMA-targeting agents on outcomes with…
Praneeth Reddy Sudalagunta, PhD, applied research scientist, Moffitt Cancer Center, Tampa, Florida, discusses the differential effects of bridging therapy on the immune microenvironment as well as outcomes with…
A new tool in the fight against Barrett’s Esophagus shows promise. A recent study by Dr. Nicholas Shaheen, director of the University of North Carolina Center for Functional…
NEW YORK (Reuters Health) – Transvaginal sonography (TVS) is superior to symptom analysis for detecting ovarian cancer, while symptom analysis is better able to distinguish benign tumors, according…
NEW YORK (Reuters Health) – New research suggests that regardless of how hormone therapy is given, it increases the risk of ovarian cancer. “Our study suggests an increased…
July 14, 2009 (Portland, Ore.) – One in eight women develop breast cancer in their lifetimes. Although regular mammograms can reduce breast cancer deaths by more than 30…
NEW YORK (Reuters Health) – A further analysis of data from the Women’s Health Initiative (WHI) trials indicates that the risks of hormone therapy still generally outweigh the…
NEW YORK (Reuters Health) – Both obesity and type 2 diabetes, owing to their harmful effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of the Ocular Oncology Section, Yale University School of Medicine, discusses eye tumors ranging from benign to malignant ophthalmic cancers.…
Jimmy K. Lee, MD, Director of the Cornea and Refractive Surgery Section, Yale Eye Center, discusses dry eye treatment, including lubricant drops, cyclosporin and plugging the drainage tube…
NEW YORK (Reuters Health) – Patients with early (stage I and IIA) colon cancer derive similar benefits from intensive postoperative surveillance as those with late stage IIB and…
NEW YORK (Reuters Health) – Combined positron-emission tomography and computed tomography (PET-CT) improves the staging of non-small cell lung cancer (NSCLC) and also reduces the numbers of total…
